Summary:
With an estimated 6 000 000 Jehovah's witnesses worldwide, haematologists may encounter patients who decline blood transfusions as a matter of personal belief. Here, we describe the first case of a transfusion-free allogeneic stem cell transplant (SCT) in a Jehovah's witness with CML. The patient underwent HLA-identical peripheral blood SCT after reduced-intensity conditioning with total body irradiation and fludarabine. Conditioning and the period after transplantation were uneventful, complete donor chimerism was achieved and the patient continues to be in molecular remission without significant chronic graft-versus-host disease. When treating Jehovah's witnesses with diseases that may be cured by allogeneic SCT, this approach should be kept in mind.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Muramoto O . Bioethical aspects of the recent changes in the policy of refusal of blood by Jehovah's witnesses. BMJ 2001; 322: 37–39.
McSweeney PA, Niederwieser D, Shizuru JA et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 2001; 97: 3390–3400.
Childs R, Epperson D, Bahceci E et al. Molecular remission of chronic myeloid leukaemia following a non-myeloablative allogeneic peripheral blood stem cell transplant: in vivo and in vitro evidence for a graft-versus-leukaemia effect. Br J Haematol 1999; 107: 396–400.
Mazza P, Palazzo G, Amurri B et al. Acute leukemia in Jehovah's Witnesses: a challenge for hematologists. Haematologica 2000; 85: 1221–2.
Marsh JCW, Bevan DH . Haematological care of the Jehovah's Witness patient. Br J Haematol. 2002; 119: 25–37.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zenz, T., Döhner, H. & Bunjes, D. Transfusion-free reduced-intensity conditioned allogeneic stem cell transplantation in a Jehovah's witness. Bone Marrow Transplant 32, 437–438 (2003). https://doi.org/10.1038/sj.bmt.1704121
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704121
Keywords
This article is cited by
-
Bloodless tandem autologous transplant in Jehovah’s Witness patients
Bone Marrow Transplantation (2018)
-
Autologous and allogeneic stem cell transplant in Jehovah’s Witnesses: a single-center experience on 22 patients
Bone Marrow Transplantation (2016)
-
SCT in Jehovah's Witnesses: the bloodless transplant
Bone Marrow Transplantation (2008)
-
The use of blood conservation methods in addition to erythropoietin allows myeloablative allogeneic stem cell transplantation without the use of blood products
Bone Marrow Transplantation (2006)
-
Treatment of acute myeloid leukemia in a Jehovah’s Witness
Annals of Hematology (2006)